Logo image
Back
Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments
Journal article   Peer reviewed

Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments

S.G. Joshi, M. Elias, A. Singh, F.H. Al-Saleem, D. Ancharski, Z. Nasser, T. Takahashi and L.L. Simpson
Neuroscience, v 179, pp 208-222
2011
DOI: https://doi.org/10.1016/j.neuroscience.2011.01.033
PMID: 21277940
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

antibodies botulinum toxin hemagglutinin locomotor behavior neuromuscular junction vaccination
Botulinum toxin is an agent that is typically encountered in two settings: as an agent that can cause disease (e.g. botulism), and as an agent that can be used to treat disease (i.e., a variety of neurologic disorders). In both cases it would be advantageous to develop a sound understanding of the mechanisms by which antibodies neutralize the toxin. In the present study, recombinant antigens were used to generate antibodies against the carboxyterminal half of the toxin heavy chain (HC50), the entire toxin light chain (LC), and the HA17, HA35 and HA70 components of the progenitor toxin complex. These antibodies were then evaluated for their respective abilities to alter botulinum toxin-induced changes in locomotor behavior in mice. The botulinum toxin type A complex was shown to produce dose-dependent depression of locomotor behavior within the dose range of 0.3–0.7 mouse LD50 units. At a dose of 0.5 LD50, the toxin typically reduced running behavior by 90% or more, and full recovery was not observed for approximately 4 weeks. Mice that were actively or passively vaccinated against the HC50 polypeptide were resistant to toxin action, presumably because the antibodies occluded the toxin binding domain. Interestingly, mice that were actively or passively vaccinated against LC were also resistant to toxin action. This effect may have been due to steric hindrance of the binding process. There was no scenario in which anti-HA antibodies altered the effects of toxin on locomotor behavior. This absence of effect was likely due to the fact that HAs and neurotoxin in the progenitor toxin complex spontaneously dissociate in physiologic media. ▶Local injections of botulinum toxin (gastrocnemius muscle) reduce motor behavior. ▶Antibodies against toxin heavy chain diminish toxin effects on motor behavior. ▶Antibodies against toxin light chain also diminish toxin effects on motor behavior. ▶There is a dose-response relationship between antibodies and loss of toxin activity. ▶Antibodies against hemagglutinins do not alter toxin activity.

Metrics

3 Record Views
15 citations in Web of Science
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Neurosciences
Logo image